6-39901355-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001201427.2(DAAM2):āc.2865C>Gā(p.Asp955Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_001201427.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAAM2 | NM_001201427.2 | c.2865C>G | p.Asp955Glu | missense_variant | 24/25 | ENST00000274867.9 | NP_001188356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAAM2 | ENST00000274867.9 | c.2865C>G | p.Asp955Glu | missense_variant | 24/25 | 1 | NM_001201427.2 | ENSP00000274867.4 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000963 AC: 24AN: 249224Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135204
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461672Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 727126
GnomAD4 genome AF: 0.000322 AC: 49AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000389 AC XY: 29AN XY: 74468
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.2865C>G (p.D955E) alteration is located in exon 24 (coding exon 23) of the DAAM2 gene. This alteration results from a C to G substitution at nucleotide position 2865, causing the aspartic acid (D) at amino acid position 955 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
DAAM2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 14, 2024 | The DAAM2 c.2865C>G variant is predicted to result in the amino acid substitution p.Asp955Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.12% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at